Privia Health Q2 revenue +21.4% to $632.6M; net income +237% to $9.0M on operating leverage

Filed August 6, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 7, 2025 · ~2 min read

Key Changes

• high

  Net income surged 236.7% to $9.0M ($0.07 diluted EPS, +250%) in Q2 2026 from $2.7M in Q2 2025, driven by operating income growth (+253% to $11.8M) that outpaced a 48.4% effective tax rate (up from 32.8% prior year due to unfavorable equity-award tax impacts and expanded 162(m) limits).

  MD&A: Operating Results; Notes: Income Taxes verify on EDGAR →
• high

  OIG inquiry disclosed March 2026 regarding a single former Mid-Atlantic obstetric/gynecological practice's medical-device procurement compliance; company made voluntary disclosure to federal and state authorities and states it does not currently believe the matter will have a material adverse effect, though outcome is uncertain.

  Notes: Commitments and Contingencies verify on EDGAR →
• high

  Attributed Lives grew 19.2% YoY to 1.647M as of June 30, 2026, driven primarily by December 2025 acquisition of an ACO business from Evolent Health adding 120,000+ lives across MSSP, commercial, and Medicare Advantage programs.

  MD&A: Key Metrics verify on EDGAR →